These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24356939)

  • 1. Transcriptome-based functional classifiers for direct immunotoxicity.
    Shao J; Berger LF; Hendriksen PJ; Peijnenburg AA; van Loveren H; Volger OL
    Arch Toxicol; 2014 Mar; 88(3):673-89. PubMed ID: 24356939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful validation of genomic biomarkers for human immunotoxicity in Jurkat T cells in vitro.
    Schmeits PC; Shao J; van der Krieken DA; Volger OL; van Loveren H; Peijnenburg AA; Hendriksen PJ
    J Appl Toxicol; 2015 Jul; 35(7):831-41. PubMed ID: 25424538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicogenomics-based identification of mechanisms for direct immunotoxicity.
    Shao J; Katika MR; Schmeits PC; Hendriksen PJ; van Loveren H; Peijnenburg AA; Volger OL
    Toxicol Sci; 2013 Oct; 135(2):328-46. PubMed ID: 23824090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CXCL12-mediated chemotaxis of Jurkat cells by direct immunotoxicants.
    Shao J; Stout I; Volger OL; Hendriksen PJ; van Loveren H; Peijnenburg AA
    Arch Toxicol; 2016 Jul; 90(7):1685-94. PubMed ID: 26314263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the usefulness of the murine cytotoxic T cell line CTLL-2 for immunotoxicity screening by transcriptomics.
    Schmeits PC; Volger OL; Zandvliet ET; van Loveren H; Peijnenburg AA; Hendriksen PJ
    Toxicol Lett; 2013 Feb; 217(1):1-13. PubMed ID: 23253260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicogenomics in the assessment of immunotoxicity.
    Baken KA; Vandebriel RJ; Pennings JL; Kleinjans JC; van Loveren H
    Methods; 2007 Jan; 41(1):132-41. PubMed ID: 17161310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity.
    Sakai R; Kondo C; Oka H; Miyajima H; Kubo K; Uehara T
    Toxicology; 2014 Jan; 315():8-16. PubMed ID: 24211769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic profile indicative of immunotoxic exposure: in vitro studies in peripheral blood mononuclear cells.
    Hochstenbach K; van Leeuwen DM; Gmuender H; Stølevik SB; Nygaard UC; Løvik M; Granum B; Namork E; van Delft JH; van Loveren H
    Toxicol Sci; 2010 Nov; 118(1):19-30. PubMed ID: 20702593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The accuracy of extended histopathology to detect immunotoxic chemicals.
    Germolec DR; Kashon M; Nyska A; Kuper CF; Portier C; Kommineni C; Johnson KA; Luster MI
    Toxicol Sci; 2004 Dec; 82(2):504-14. PubMed ID: 15342959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis of the human T lymphocyte cell line Jurkat and human peripheral blood mononuclear cells exposed to deoxynivalenol (DON): New mechanistic insights.
    Katika MR; Hendriksen PJ; Shao J; van Loveren H; Peijnenburg A
    Toxicol Appl Pharmacol; 2012 Oct; 264(1):51-64. PubMed ID: 22846391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective.
    Herwig R; Gmuender H; Corvi R; Bloch KM; Brandenburg A; Castell J; Ceelen L; Chesne C; Doktorova TY; Jennen D; Jennings P; Limonciel A; Lock EA; McMorrow T; Phrakonkham P; Radford R; Slattery C; Stierum R; Vilardell M; Wittenberger T; Yildirimman R; Ryan M; Rogiers V; Kleinjans J
    Arch Toxicol; 2016 Sep; 90(9):2215-2229. PubMed ID: 26525393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a toxicogenomics in vitro assay for the efficient characterization of compounds.
    Yang Y; Abel SJ; Ciurlionis R; Waring JF
    Pharmacogenomics; 2006 Mar; 7(2):177-86. PubMed ID: 16515397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differentially-expressed genes potentially implicated in drought response in pitaya (Hylocereus undatus) by suppression subtractive hybridization and cDNA microarray analysis.
    Fan QJ; Yan FX; Qiao G; Zhang BX; Wen XP
    Gene; 2014 Jan; 533(1):322-31. PubMed ID: 24076355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding maximal transcriptome differences between reprotoxic and non-reprotoxic phthalate responses in rat testis.
    Yuan X; Jonker MJ; de Wilde J; Verhoef A; Wittink FR; van Benthem J; Bessems JG; Hakkert BC; Kuiper RV; van Steeg H; Breit TM; Luijten M
    J Appl Toxicol; 2011 Jul; 31(5):421-30. PubMed ID: 21061450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests.
    Luster MI; Portier C; Pait DG; White KL; Gennings C; Munson AE; Rosenthal GJ
    Fundam Appl Toxicol; 1992 Feb; 18(2):200-10. PubMed ID: 1534777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and identification of reliable reference genes for pharmacogenomics, toxicogenomics, and small RNA expression analysis.
    Chen D; Pan X; Xiao P; Farwell MA; Zhang B
    J Cell Physiol; 2011 Oct; 226(10):2469-77. PubMed ID: 21412770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process.
    Luebke RW; Holsapple MP; Ladics GS; Luster MI; Selgrade M; Smialowicz RJ; Woolhiser MR; Germolec DR
    Toxicol Sci; 2006 Nov; 94(1):22-7. PubMed ID: 16882865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a toxicogenomics signature for genotoxicity using a dose-optimization and informatics strategy in human cells.
    Li HH; Hyduke DR; Chen R; Heard P; Yauk CL; Aubrecht J; Fornace AJ
    Environ Mol Mutagen; 2015 Jul; 56(6):505-19. PubMed ID: 25733355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hepatotoxicity: a predictive model based on focused illumina microarrays.
    Zidek N; Hellmann J; Kramer PJ; Hewitt PG
    Toxicol Sci; 2007 Sep; 99(1):289-302. PubMed ID: 17522070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.